JPH0710734A - Cosmetic - Google Patents

Cosmetic

Info

Publication number
JPH0710734A
JPH0710734A JP5173788A JP17378893A JPH0710734A JP H0710734 A JPH0710734 A JP H0710734A JP 5173788 A JP5173788 A JP 5173788A JP 17378893 A JP17378893 A JP 17378893A JP H0710734 A JPH0710734 A JP H0710734A
Authority
JP
Japan
Prior art keywords
yeast
effect
cosmetic
cells
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5173788A
Other languages
Japanese (ja)
Inventor
Masayuki Iwata
雅之 岩田
Kenta Tabuchi
健太 田淵
Makiko Yanagisawa
真樹子 柳沢
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dowa Holdings Co Ltd
Original Assignee
Dowa Mining Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dowa Mining Co Ltd filed Critical Dowa Mining Co Ltd
Priority to JP5173788A priority Critical patent/JPH0710734A/en
Publication of JPH0710734A publication Critical patent/JPH0710734A/en
Pending legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PURPOSE:To prepare a cosmetic compounded with an ingredient having effects on the prevention of the production of melamine causing stains, freckles, dark skin due to sunburn, etc., and on the lightening of deposited pigments when applied to skins, and capable of making white and beautiful skins. CONSTITUTION:The characteristic of this cosmetic comprises compounding a fermentation solution prepared by inoculating and culturing the genus Saccharomyces yeast separated from kefir particles in a medium containing milk ingredients as main ingredients and subsequently removing the cells of the yeast from the obtained culture solution.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、優れた皮膚美白効果、
活性酸素消去効果および細胞賦活効果を有する化粧料に
関し、さらに詳しくは、サッカロマイセス属酵母培養液
から得られた発酵液を有効成分として配合した化粧料に
関する。・
BACKGROUND OF THE INVENTION The present invention has an excellent skin whitening effect,
The present invention relates to a cosmetic having an active oxygen scavenging effect and a cell activating effect, and more specifically to a cosmetic containing a fermentation broth obtained from a Saccharomyces yeast culture broth as an active ingredient.・

【0002】[0002]

【従来の技術】一般に、日焼けによる色黒、シミ、ソバ
カス等は、黒褐色の色素であるメラニンの生成により生
じるものと考えられており、このメラニンは、皮膚が紫
外線などの外的刺激を受けると、皮膚のメラニン細胞中
に存在するチロシナーゼ(チロシン酸化酵素)が活性化
し、たんぱく質構成アミノ酸の一種であるチロシンが酸
化されて生成する。このことから、メラニン生成に関与
するチロシナーゼの活性を抑制することにより肌を白く
する効果が期待されるため、チロシナーゼ活性抑制成分
の化粧料への配合が提唱されていた。
2. Description of the Related Art Generally, it is considered that dark skin, spots, freckles, etc. due to sunburn are caused by the production of melanin which is a blackish brown pigment. , Tyrosinase (tyrosine oxidase) present in melanocytes of the skin is activated, and tyrosine, which is one of the protein-constituting amino acids, is oxidized and produced. From this, since it is expected that the effect of whitening the skin by suppressing the activity of tyrosinase involved in melanin production is expected, the incorporation of a tyrosinase activity suppressing component into cosmetics has been proposed.

【0003】しかしながら、チロシナーゼ活性抑制効果
を示すものの、B16メラノーマ培養細胞においてメラ
ニン生成抑制効果が弱かったり、実際に皮膚に適用した
場合、沈着した色素の淡色化の効果が充分でない化粧料
が多かった。
[0003] However, many cosmetics have an effect of suppressing tyrosinase activity, but have a weak effect of suppressing melanin production in cultured cells of B16 melanoma, or have an insufficient effect of lightening the deposited pigment when actually applied to the skin. .

【0004】実際に化粧料を皮膚に適用した場合に美白
効果を発揮させるためには、上述のチロシナーゼ活性抑
制効果やメラニン生成抑制効果のみでは不充分であり、
これらの効果の他、活性酸素を消去することによる色素
沈着の抑制や表皮細胞の賦活によるメラニン排泄の促進
などの効果も必要とされている。
In order to actually exert the whitening effect when the cosmetic is applied to the skin, the above-mentioned tyrosinase activity suppressing effect and melanin production suppressing effect alone are insufficient,
In addition to these effects, effects such as suppression of pigmentation by eliminating active oxygen and promotion of melanin excretion by activation of epidermal cells are also required.

【0005】一方、酵母を利用する化粧料として特開昭
61−53208号公報「皮膚化粧料」、特開昭61−
260009号公報「酵母抽出液」、特開昭62−23
4007号公報「酵母の生産する抗菌物質を含有する皮
膚化粧品」、特開昭63−277605号公報「化粧
料」、特開昭64−63505公報「化粧料」や特開平
3−163168号公報「赤色色素とその製造方法なら
びに飯食品または化粧料」などによって公知であるが、
これら従来の酵母を利用した化粧料は、ビール酵母、パ
ン酵母の抽出物を利用したものが多く、美白効果を持た
ないものが多いのが現状である。
On the other hand, as a cosmetic using yeast, JP-A-61-53208, "Skin cosmetic", JP-A-61-53208
260009, "Yeast Extract", JP-A-62-23
No. 4007, "Skin cosmetics containing antibacterial substances produced by yeast", JP-A-63-277605, "Cosmetics", JP-A-64-63505, "Cosmetics" and JP-A-3-163168. Red dye and its manufacturing method and rice food or cosmetics "and the like,
Most of these conventional cosmetics using yeasts use extracts of brewer's yeast and baker's yeast, and most of them do not have a whitening effect.

【0006】[0006]

【発明が解決しようとする課題】本発明は、上述の従来
の技術の問題点を解決し、チロシナーゼ活性抑制、メラ
ニン生成抑制、活性酸素消去や細胞賦活に基づく優れた
皮膚美白効果を有し、且つ安全な化粧料を提供すること
を目的とするものである。
DISCLOSURE OF THE INVENTION The present invention solves the problems of the above-mentioned conventional techniques and has an excellent skin whitening effect based on tyrosinase activity inhibition, melanin production inhibition, active oxygen elimination and cell activation, In addition, the purpose is to provide a safe cosmetic product.

【0007】[0007]

【課題を解決するための手段】本発明者等は斯かる課題
を解決するために鋭意研究したところ、サッカロマイセ
ス属酵母培養液から得られた発酵液が上述に示す諸効果
を併せ有することを見出し、本発明を提供することがで
きた。
Means for Solving the Problems The inventors of the present invention have conducted diligent research to solve such problems, and found that a fermentation broth obtained from a Saccharomyces yeast culture broth has the above-mentioned various effects. The present invention can be provided.

【0008】すなわち、本発明は、牛乳成分を主成分と
する培地に、ケフィア(Kefir )粒から分離したサッカ
ロマイセス(Saccharomyces )属酵母を接種し培養を行
い、得られた培養液から酵母菌体を除去することによっ
て調製された発酵液を配合して成ることを特徴とする化
粧料に関するものである。
That is, according to the present invention, a medium containing milk components as a main component is inoculated with a yeast of the genus Saccharomyces separated from Kefir grains and cultivated, and yeast cells are obtained from the obtained culture solution. The present invention relates to a cosmetic comprising a fermentation liquor prepared by removing it.

【0009】[0009]

【作用】本発明で使用する酵母は、コーカサス地方が発
祥の地と考えられている伝統的な発酵乳ケフィアのスタ
ータであるケフィア粒から分離した酵母であり、醸造用
酵母やパン酵母と同様に人類が長期間に渡って食用に供
して来た安全性の高い酵母である。
The yeast used in the present invention is a yeast separated from kefir grains, which is a starter of traditional fermented milk kefir, which is considered to originate in the Caucasus region, and is similar to brewing yeast and baker's yeast. It is a highly safe yeast that has been used by humankind for a long period of time.

【0010】本発明においては、クリスチャン・ハンセ
ン社製の市販ケフィア粒から分離した乳糖資化性サッカ
ロマイセス属の酵母を用いることにした。
In the present invention, a lactose-utilizing yeast of the genus Saccharomyces isolated from commercial kefir grains manufactured by Christian Hansen Co., Ltd. is used.

【0011】この場合、上記酵母を培養するための培地
としては、牛乳、あるいは5〜20%還元脱脂乳を使用
し、次いで、該酵母を接種して20〜30℃の温度で、
2〜7日間攪拌培養あるいは通気攪拌培養する。
In this case, cow's milk or 5 to 20% reduced skim milk is used as a medium for culturing the yeast, and the yeast is then inoculated at a temperature of 20 to 30 ° C.
Stir culture or aeration stir culture for 2 to 7 days.

【0012】次いで得られた培養液をそのままただちに
遠心分離機や濾過によって酵母菌体やカゼイン等の不溶
成分を除き、目的の発酵液を得るが、この場合、得られ
た培養液1容量部に対して0.5〜2容量部のメタノー
ルやエタノールを単独あるいは混合液とした溶剤を添加
して20〜40℃の温度で、2〜24時間攪拌した後、
遠心分離機や濾過によって酵母菌体やガゼイン等の不溶
成分を除いて、目的の発酵液を得てもよい。
Then, the obtained culture broth is immediately removed by centrifugation or filtration to remove insoluble components such as yeast cells and casein to obtain a desired fermentation broth. In this case, 1 volume part of the obtained culture broth is used. On the other hand, after adding a solvent containing 0.5 to 2 parts by volume of methanol or ethanol alone or a mixed solution and stirring at a temperature of 20 to 40 ° C. for 2 to 24 hours,
The target fermentation broth may be obtained by removing insoluble components such as yeast cells and casein by a centrifuge or filtration.

【0013】このようにして得られた発酵液は、チロシ
ナーゼ活性抑制効果、B16メラノーマ細胞におけるメ
ラニン生成抑制効果、活性酸素消去効果、細胞賦活効果
および茶色モルモットの皮膚における沈着色素の淡色化
効果を有することが、本発明者の試験によって確認され
ている。
The fermented liquor thus obtained has an effect of suppressing tyrosinase activity, an effect of suppressing melanin production in B16 melanoma cells, an effect of scavenging active oxygen, a cell activating effect and a lightening effect of a deposition pigment on the skin of brown guinea pigs. This has been confirmed by the inventors' tests.

【0014】この発酵液を、化粧水、クリーム、乳液、
パック等の中に0.05〜10%配合することによっ
て、皮膚美白効果、活性酸素消去効果および細胞賦活効
果を有する化粧料を得ることができる。
This fermented liquid was used as a lotion, cream, emulsion,
By blending 0.05 to 10% in a pack or the like, a cosmetic having a skin whitening effect, an active oxygen scavenging effect and a cell activating effect can be obtained.

【0015】以下、実施例により本発明をさらに詳細に
説明するが、本発明の範囲はこれらに限定されるもので
はない。
Hereinafter, the present invention will be described in more detail with reference to Examples, but the scope of the present invention is not limited thereto.

【0016】[0016]

【実施例1】ケフィア粒からサッカロマイセス属酵母の
分離。
Example 1 Separation of Saccharomyces yeast from kefir grains.

【0017】クリスチャン・ハンセン社(デンマーク国
コペンハーゲン)により入手したケフィア粒を、105
℃で20分間殺菌した10%還元脱脂乳に接種し、20
〜22℃で毎日植え継ぎ、ケフィア粒を活性化させた。
次いで、活性化したケフィア粒2gを滅菌した乳鉢に採
取し、滅菌生理食塩水2mlを加え、ケフィア粒を充分に
摩砕した。
105 kefir grains obtained from Christian Hansen (Copenhagen, Denmark)
Inoculate 10% reduced skim milk sterilized at ℃ for 20 minutes,
Kefir grains were activated by subculture daily at -22 ° C.
Next, 2 g of the activated kefir grains were collected in a sterilized mortar, and 2 ml of sterilized physiological saline was added to sufficiently crush the kefir grains.

【0018】次に、微細化したケフィア粒を含む懸濁液
を滅菌生理食塩水で10段階に希釈し、適当な希釈段階
の希釈液0.1mlをあらかじめ作製しておいたYM寒天
培地(理化学研究所発行微生物株カタログ第5版、19
92年、396ページ記載)上に塗布し、25℃で4日
間培養した。
Next, the suspension containing the finely divided kefir grains was diluted with sterile physiological saline in 10 steps, and 0.1 ml of a diluting solution at an appropriate dilution step was prepared in advance on a YM agar medium (physical and chemical). Laboratory-published microbial strain catalog 5th edition, 19
1992 (see page 396), and cultured at 25 ° C. for 4 days.

【0019】光学顕微鏡を用いて、生じたコロニーの中
から楕円形を示す酵母菌を20株分離し、それぞれ、あ
らたなYM寒天培地でシングルコロニーアイソレーショ
ンを3回繰り返して純化した。このようにして得られた
分離株のうち、任意の1株を代表株サッカロマイセス属
酵母菌Y14株(工業技術院生命工学工業技術研究所寄
FERMP−13627号)として用いることとした。
Using an optical microscope, 20 yeast strains showing an elliptic shape were isolated from the resulting colonies, and each was purified by repeating single colony isolation three times on a new YM agar medium. Of the isolates thus obtained, any one strain was used as the representative strain Saccharomyces yeast strain Y14 (Institute of Biotechnology, National Institute of Biotechnology, FERMP-13627).

【0020】このサッカロマイセス属菌Y14株の菌学
的性質は、下記の通りであった。
The mycological properties of this Saccharomyces sp. Strain Y14 were as follows.

【0021】 ・形状 楕円形 ・増殖様式 出芽 ・YM寒天培地状のコロニーの性状 円形、白色 ・乳糖資化性 あり・ Shape Ellipse ・ Proliferation pattern Sprouting ・ YM agar-like colony properties Round, white ・ Lactose assimilating

【0022】[0022]

【実施例2】 酵母発酵液の調製。Example 2 Preparation of yeast fermentation broth.

【0023】10%還元脱脂乳2リットルを110℃で
20分間高圧滅菌したものを培地とした。次いで該培地
に、予め同様の培地50mlを用いて前培養しておいたサ
ッカロマイセス属酵母Y14株の培養液を接種し、25
℃で5日間通気攪拌培養した(通気量2リットル/分、
回転数200回転/分)。
A medium was prepared by autoclaving 2 liters of 10% reduced skim milk at 110 ° C. for 20 minutes. Then, the medium was inoculated with a culture solution of the Saccharomyces yeast Y14 strain that had been precultured in advance using 50 ml of the same medium.
Culture was performed with aeration and agitation for 5 days (aeration rate of 2 liters / minute,
Rotation speed 200 rotations / minute).

【0024】培養終了後、培養液に3リットルのエタノ
ールを加え、25℃で18時間攪拌した。次いで、この
液を遠心分離(8,000×g、15分間)により約
4.4リットルの上清を得、さらにこの上清に1規定塩
酸を適量添加することによってpHを4.6に調整し、
−20℃で18時間放置した後、濾過によって沈殿物を
除き濾液を得た。
After the completion of the culture, 3 liters of ethanol was added to the culture medium, and the mixture was stirred at 25 ° C. for 18 hours. Then, this solution was centrifuged (8,000 × g, 15 minutes) to obtain about 4.4 liters of a supernatant, and 1N hydrochloric acid was added to this supernatant in an appropriate amount to adjust the pH to 4.6. Then
After standing at -20 ° C for 18 hours, the precipitate was removed by filtration to obtain a filtrate.

【0025】次いで、この濾液に1規定水酸化ナトリウ
ム水溶液を適量添加することによってpHを6.8に調
整し、−20℃で18時間放置した後、濾過によって沈
殿物を除き、淡黄色透明な酵母発酵液を4.2リットル
得た。
Then, the pH of the filtrate was adjusted to 6.8 by adding an appropriate amount of 1N sodium hydroxide aqueous solution, the mixture was allowed to stand at -20 ° C. for 18 hours, the precipitate was removed by filtration, and the mixture was pale yellow and transparent. 4.2 liters of yeast fermented liquid was obtained.

【0026】[0026]

【実施例3】チロシナーゼ活性抑制率の測定試験。Example 3 A test for measuring the tyrosinase activity inhibition rate.

【0027】先ず、実施例2で得られた酵母発酵液1m
l、2ml、3ml、4ml、5mlを減圧乾燥した後、それぞ
れに0.1mlの蒸留水を添加して溶解し、これらの溶液
を以下の試験における試験溶液とした。
First, 1 m of the yeast fermentation broth obtained in Example 2
l, 2 ml, 3 ml, 4 ml, and 5 ml were dried under reduced pressure, and 0.1 ml of distilled water was added to each to dissolve, and these solutions were used as test solutions in the following tests.

【0028】試験管に100mMコハク酸ナトリウム緩衝
液(pH5.5)1.8mlと、270units /mlマッシ
ュルームチロシナーゼ(シグマ社製)溶液0.1mlおよ
び上記の試料溶液0.1mlをそれぞれ個別に入れて混合
し、30℃の恒温水槽で15分間インキュベートした。
In a test tube, 1.8 ml of 100 mM sodium succinate buffer (pH 5.5), 0.1 ml of 270 units / ml mushroom tyrosinase (manufactured by Sigma) and 0.1 ml of the above sample solution were separately charged. The mixture was mixed and incubated in a constant temperature water bath at 30 ° C. for 15 minutes.

【0029】次いで、この個別の各試験管に6mM L−
DOPA溶液(和光純薬工業製:上記100mMコハク酸
ナトリウム緩衝液に溶解したもの)1mlを加えて攪拌し
た後、この各試験管を30℃の恒温室中に設置した往復
振とう機に約45°傾けてセットし、40分間振とう
(往復回数150回/分)した。その後、分光光度計を
用いて475nmの吸光度を測定し、その測定値を(A)
とした。
Then, 6 mM L- was added to each of the individual test tubes.
After adding 1 ml of DOPA solution (manufactured by Wako Pure Chemical Industries: dissolved in the above 100 mM sodium succinate buffer) and stirring, each test tube was placed in a constant temperature chamber at 30 ° C. for about 45 minutes on a reciprocal shaker. The sample was tilted and set, and shaken for 40 minutes (reciprocating frequency 150 times / minute). After that, the absorbance at 475 nm was measured using a spectrophotometer, and the measured value was (A).
And

【0030】一方、対照液として、試料溶液の代わりに
蒸留水を加えたこと以外は上記と同様にして475nmの
吸光度を測定し、その測定値を(B)とした。また、L
−DOPA溶液の代わりに上記コハク酸ナトリウムを加
えたこと以外は上記と同様にして475nmの吸光度を測
定し、その測定値を(C)とした。
On the other hand, as a control liquid, the absorbance at 475 nm was measured in the same manner as above except that distilled water was added instead of the sample solution, and the measured value was designated as (B). Also, L
The absorbance at 475 nm was measured in the same manner as above except that the sodium succinate was added instead of the DOPA solution, and the measured value was designated as (C).

【0031】なお、試料溶液のチロシナーゼ活性抑制率
の算出は、以下の計算式を用いて行ない、その結果を表
1に示した。 チロシナーゼ活性抑制率(%)={1−(A−C)/
B}×100
The tyrosinase activity inhibition rate of the sample solution was calculated using the following formula, and the results are shown in Table 1. Tyrosinase activity inhibition rate (%) = {1- (AC) /
B} × 100

【0032】[0032]

【表1】 [Table 1]

【0033】[0033]

【実施例4】B16メラノーマ細胞におけるメラニン生
成抑制率の測定試験。
Example 4 Measurement test of melanin production suppression rate in B16 melanoma cells.

【0034】先ず、実施例2で得た酵母発酵液1ml、2
ml、3ml、4ml、5mlを減圧乾燥した後、それぞれ0.
1mlの蒸留水に溶解し、これらの溶液を以下の試験にお
ける試料溶液とした。
First, 1 ml of the yeast fermentation broth obtained in Example 2
ml, 3 ml, 4 ml, and 5 ml were dried under reduced pressure, and then each of the
Dissolved in 1 ml of distilled water, these solutions were used as sample solutions in the following tests.

【0035】次いで10%ウシ胎児血清を含むイーグル
MEM培地に、メラニンを生成するマウス由来の悪性黒
色腫胞であるB16メラノーマ細胞(B16−FO.A
TCC No.CRU−6322)を終濃度3×103
/mlとなるように接種した後、この培地を6ウェルプレ
ート(FALCON社製)の各ウェルに6ml入れ、CO
2 インキュベーター(5%CO2 、37℃)内で5日間
培養した。
Then, in an Eagle MEM medium containing 10% fetal bovine serum, B16 melanoma cells (B16-FO.A), which are melanin-producing malignant melanoma cells of mouse origin.
TCC No. CRU-6322) at a final concentration of 3 × 10 3.
After inoculating so that the amount of the culture medium becomes / ml, 6 ml of this medium is put into each well of a 6-well plate (FALCON) and CO
The cells were cultured in a 2 incubator (5% CO 2 , 37 ° C) for 5 days.

【0036】次いで、この培地を0.03%ティオフィ
リン(シグマ社製)を含む上記組成の新規イーグルME
M培地(6ml)に交換し、各ウェルに上記試料溶液
(0.1ml)、あるいは対照として用いた物質の溶液を
添加した後、さらに3日間培養した。
Then, this medium was added to the novel Eagle ME containing 0.03% theophylline (manufactured by Sigma) and having the above composition.
The medium was replaced with M medium (6 ml), and the sample solution (0.1 ml) or the solution of the substance used as a control was added to each well, followed by culturing for 3 days.

【0037】培養終了後、培地を捨てて、各ウェルに1
mlの生理食塩水を加え、スクレーパーを用いてウェルの
底に付着している細胞を書き取るように懸濁させ、次い
でピペットを用いて該細胞懸濁液をマイクロ遠心チュー
ブ(1.5ml容量、エッペンドルフ社製)に移し、遠心
分離(1,000×g、15分間)した。
After culturing, the medium is discarded and 1 well is added to each well.
ml of physiological saline is added, and the cells attached to the bottom of the well are suspended using a scraper so that the cells are marked down. Then, the cell suspension is pipetted into a microcentrifuge tube (1.5 ml volume, Eppendorf). (Made by the company) and centrifuged (1,000 xg, 15 minutes).

【0038】次いで遠心分離後の上清を除いた後、終容
量1mlとなるように生理食塩水を加え、ペレットとなっ
た細胞を懸濁し、細胞懸濁液となし、該細胞懸濁液に1
0%SDS溶液20μlを加えて激しく攪拌し、細胞を
溶解させた。
After removing the supernatant after centrifugation, physiological saline was added so that the final volume was 1 ml, and the pelleted cells were suspended to form a cell suspension. 1
20 μl of 0% SDS solution was added and vigorously stirred to lyse the cells.

【0039】次いで分光光度計を用いて上記の細胞溶解
液の260nmの吸光度(A)と475nmの吸光度(B)
とをそれぞれ測定した。一方、対照として試料溶液の代
わりに滅菌水を添加して上記同様の試験を行い、260
nmの吸光度(C)と475nmの吸光度(D)とを測定し
て、以下の計算式を用いてメラニン抑制率の算出を行
い、その結果を表2に示した。
Then, using a spectrophotometer, the absorbance at 260 nm (A) and the absorbance at 475 nm (B) of the above cell lysate.
And were measured respectively. On the other hand, as a control, sterilized water was added instead of the sample solution and the same test as above was performed.
The absorbance (C) at nm and the absorbance (D) at 475 nm were measured, and the melanin inhibition rate was calculated using the following formula, and the results are shown in Table 2.

【0040】メラニン生成抑制率(%)={1−(B/
A)/(D/C)}×100
Melanin production inhibition rate (%) = {1- (B /
A) / (D / C)} × 100

【0041】[0041]

【表2】 [Table 2]

【0042】[0042]

【実施例5】茶色モルモットにおける沈着色素の淡色化
効果の測定試験。
[Example 5] A test for measuring the lightening effect of a deposited pigment in a brown guinea pig.

【0043】A−1系茶色モルモット(雄、実験開始時
体重400g)の背部を剃毛して皮膚を露出させ、紫外
線(波長312nm、強度420mJ)を1日1回照射し、
これを5日間繰り返した。その後、無処置で飼育を続
け、7日後に皮膚の色素沈着を得た。
A-1 brown guinea pig (male, body weight 400 g at the start of the experiment) was shaved on the back to expose the skin, and irradiated with ultraviolet rays (wavelength 312 nm, intensity 420 mJ) once a day,
This was repeated for 5 days. After that, the animal was kept without treatment, and after 7 days, skin pigmentation was obtained.

【0044】次に、色素沈着部位を2cm×2cmの正方形
に区画し、1区画に対して、実施例2で得られた酵母発
酵液を1日1回50μl塗布し、これを20日間繰り返
した。また対照として、60%エタノール溶液、蒸留水
も同様に塗布して色素沈着の淡色化効果を求めた。
Next, the pigmentation site was divided into 2 cm × 2 cm squares, and 50 μl of the yeast fermentation broth obtained in Example 2 was applied to one section once a day, and this was repeated for 20 days. . As a control, a 60% ethanol solution and distilled water were also applied in the same manner to determine the pigmentation lightening effect.

【0045】この場合、色素沈着の淡色化効果は、上記
塗布試料を20日間塗布し、以下に示す判定基準にした
がって肉眼判定をすることによって求め、その結果を表
3に示した。
In this case, the lightening effect of pigmentation was determined by applying the above-mentioned coated sample for 20 days and visually determining it according to the following criteria, and the results are shown in Table 3.

【0046】判定基準 0 : 無塗布部位と比べ、色素沈着の差が認められな
い。 1 : 無塗布部位と比べ、わずかに沈着色素の淡色化
が認められる。 2 : 無塗布部位と比べ、中程度の沈着色素の淡色化
が認められる。 3 : 無塗布部位と比べ、顕著な沈着色素の淡色化が
認められる。
Criteria 0: No difference in pigmentation is recognized as compared with the non-coated area. 1: A slight lightening of the deposited pigment is observed as compared with the uncoated area. 2: Moderate lightening of the deposited pigment is recognized as compared with the uncoated area. 3: Significant lightening of the deposited pigment is recognized as compared with the uncoated area.

【0047】[0047]

【表3】 [Table 3]

【0048】[0048]

【実施例6】活性酸素消去効果の測定試験。[Example 6] A test for measuring the effect of eliminating active oxygen.

【0049】先ず、実施例2で得た酵母発酵液1ml、2
ml、3ml、4ml、5mlを減圧乾燥した後、それぞれ0.
1mlの蒸留水に溶解し、これらの溶液を以下の試験の試
料溶液とした。
First, 1 ml of the yeast fermentation broth obtained in Example 2
ml, 3 ml, 4 ml, and 5 ml were dried under reduced pressure, and then each of the
Dissolved in 1 ml of distilled water, these solutions were used as sample solutions for the following tests.

【0050】活性酸素消去効果の測定法は、スーパーオ
キサイド・ディスムターゼ(SOD)の活性測定法のう
ち、チトクロームCを用いる方法に準じて、以下のよう
に行なった。
The active oxygen scavenging effect was measured in the following manner according to the method using cytochrome C in the superoxide dismutase (SOD) activity measuring method.

【0051】分光光度計キュベット(4ml容量、光路1
cm)に、100mMトリス塩酸緩衝液(pH7.8)を
2.6ml、1mMチトクロームC溶液(上記トリス塩酸緩
衝液に溶解したもの)を0.1ml、キサンチンオキシダ
ーゼ溶液(ベーリンガーマンハイム社製、製品番号11
0434を上記トリス塩酸緩衝液で80倍に希釈したも
の)を0.1ml、試料溶液を0.1ml、および15mMキ
サンチン溶液(0.025規定NaOH溶液に溶解した
もの)を0.1ml加え、攪拌した後、30℃の恒温キュ
ベットホルダーをセットした分光光度計により、550
nmの吸光度の変化(増加)を測定し、その増加速度の初
速をVとした。
Spectrophotometer cuvette (4 ml capacity, light path 1
cm), 2.6 ml of 100 mM Tris-HCl buffer (pH 7.8), 0.1 ml of 1 mM Cytochrome C solution (dissolved in the above Tris-HCl buffer), xanthine oxidase solution (Boehringer Mannheim, product number) 11
0.1 ml of 0434 diluted with the above Tris-HCl buffer), 0.1 ml of sample solution, and 0.1 ml of 15 mM xanthine solution (dissolved in 0.025N NaOH solution) were added and stirred. Then, using a spectrophotometer with a 30 ° C constant temperature cuvette holder set,
The change (increase) in the absorbance at nm was measured, and the initial speed of the increase rate was V.

【0052】一方、対照として、試料溶液の代わりに蒸
留水0.1mlを加えた場合についても同様に吸光度の変
化を測定し、そのときの吸光度の増加速度の初速をV0
として、以下の計算式を用いて活性酸素消去率の算出を
行い、その結果を表4に示した。
On the other hand, as a control, when 0.1 ml of distilled water was added instead of the sample solution, the change in absorbance was measured in the same manner, and the initial rate of increase in absorbance at that time was V 0.
As a result, the active oxygen scavenging rate was calculated using the following formula, and the results are shown in Table 4.

【0053】 活性酸素消去率(%)=(1−V/V0 )×100Active oxygen scavenging rate (%) = (1−V / V 0 ) × 100

【0054】[0054]

【表4】 [Table 4]

【0055】[0055]

【実施例7】細胞賦活効果の測定試験。Example 7: Test for measuring cell activation effect.

【0056】先ず、実施例2で得た酵母発酵液1ml、2
ml、3ml、4ml、5mlを減圧乾燥した後、それぞれ0.
1mlの蒸留水に溶解し、これらの溶液を以下の試験の試
料溶液とした。
First, 1 ml of the yeast fermentation broth obtained in Example 2 and 2
ml, 3 ml, 4 ml, and 5 ml were dried under reduced pressure, and then each of the
Dissolved in 1 ml of distilled water, these solutions were used as sample solutions for the following tests.

【0057】10%ウシ胎児血清を含むイーグルMEM
培地に、ヒト由来正常繊維細胞(CCD−45SK.A
TCC No.CRL−1506)を終濃度1×104
/mlとなるように接種した後、この培地を6ウェルプレ
ート(FALCON社製)の各ウェルに5ml入れ、CO
2 インキュベーター(5%CO2 、37℃)内で24時
間培養し、次いで、培地を1%ウシ胎児血清を含むイー
グルMEM培地に交換し、各ウェルに上記試料溶液
(0.1ml)、あるいは対照として蒸留水の0.1mlを
添加し、さらに5日間培養した。
Eagle MEM with 10% fetal bovine serum
Human-derived normal fiber cells (CCD-45SK.A) were added to the medium.
TCC No. CRL-1506) at a final concentration of 1 × 10 4
After inoculating so that the amount of the culture medium becomes / ml, 5 ml of this medium is put into each well of a 6-well plate (FALCON) and CO
2 incubator (5% CO 2, 37 ℃ ) 24 hours and cultured in, then medium was changed to Eagles MEM medium containing 1% fetal calf serum, the sample solution (0.1 ml) to each well, or control Then, 0.1 ml of distilled water was added, and the cells were further cultured for 5 days.

【0058】培養後、培地を捨て、各ウェルに0.25
%トリプシン液(コージンバイオ社製)1mlを入れ、細
胞表面を洗った。トリプシン液をを捨て、もう一度新し
いトリプシン液を1ml入れ、同様の操作をした後トリプ
シン液を捨て、プレートをCO2 インキュベーターに入
れ、20分間保温した後、各ウェルに生理食塩水5mlを
入れ、緩やかにピペッティングし、細胞を懸濁した後、
細胞濃度を測定した。
After culturing, the medium is discarded and 0.25 is added to each well.
% Trypsin solution (manufactured by Kojin Bio Co., Ltd.) was added to wash the cell surface. Discard the trypsin solution, add 1 ml of fresh trypsin solution again, perform the same operation, discard the trypsin solution, put the plate in a CO 2 incubator, keep warm for 20 minutes, put 5 ml of physiological saline in each well, and gently After pipetting to suspend the cells,
Cell concentration was measured.

【0059】細胞賦活効果は、対照実験区の細胞濃度を
100とした場合の試料溶液添加実験区の細胞濃度で表
わし、その結果を表5に示した。
The cell activation effect was represented by the cell concentration of the sample solution-added experiment group, where the cell concentration of the control experiment group was 100, and the results are shown in Table 5.

【0060】[0060]

【表5】 [Table 5]

【0061】[0061]

【実施例8】化粧水の組成。Example 8 Composition of lotion.

【0062】実施例2で得られた酵母発酵液を用い、以
下に示すような配合の化粧水を製造することができる。
Using the yeast fermented liquor obtained in Example 2, a lotion having the following formulation can be produced.

【0063】 (重量%) ・酵母発酵液 10 ・グリセリン 5 ・ポリオキシエチレンソルビタンモノラウレート 1.5 ・香料 適量 ・防腐剤 適量 ・色素 適量 ・精製水 残部(Wt%) ・ Yeast fermentation liquor 10 ・ Glycerin 5 ・ Polyoxyethylene sorbitan monolaurate 1.5 ・ Perfume proper amount ・ Preservative proper amount ・ Dye proper amount ・ Purified water balance

【0064】[0064]

【発明の効果】上述のように本発明による酵母発酵液
は、チロシナーゼ活性抑制効果、メラニン生成抑制効
果、活性酸素消去効果、細胞賦活効果および茶色モルモ
ットにおける沈着色素の淡色化効果を有しており、この
酵母発酵液を配合した化粧料は優れた皮膚美白効果を発
揮するものである。
As described above, the yeast fermented liquor according to the present invention has a tyrosinase activity inhibitory effect, a melanin production inhibitory effect, an active oxygen scavenging effect, a cell activating effect and a lightening effect of a deposition pigment in brown guinea pigs. The cosmetic containing the yeast fermentation liquid exhibits an excellent skin whitening effect.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A61K 35/72 ADS 7431−4C AED 7431−4C C12P 1/02 Z 7417−4B //(C12P 1/02 C12R 1:85) ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI Technical display location A61K 35/72 ADS 7431-4C AED 7431-4C C12P 1/02 Z 7417-4B // (C12P 1 / 02 C12R 1:85)

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 牛乳成分を主成分とする培地に、ケフィ
ア(Kefir )粒から分離したサッカロマイセス(Saccha
romyces )属酵母を接種し培養を行い、得られた培養液
から酵母菌体を除去することによって調製された発酵液
を配合して成ることを特徴とする化粧料。
1. Saccharomyces (Saccha) separated from Kefir grains in a medium containing milk as a main component.
romyces) genus yeast is inoculated and cultivated, and a fermentation liquor prepared by removing yeast cells from the obtained culture broth is added to the cosmetic.
JP5173788A 1993-06-21 1993-06-21 Cosmetic Pending JPH0710734A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5173788A JPH0710734A (en) 1993-06-21 1993-06-21 Cosmetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5173788A JPH0710734A (en) 1993-06-21 1993-06-21 Cosmetic

Publications (1)

Publication Number Publication Date
JPH0710734A true JPH0710734A (en) 1995-01-13

Family

ID=15967165

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5173788A Pending JPH0710734A (en) 1993-06-21 1993-06-21 Cosmetic

Country Status (1)

Country Link
JP (1) JPH0710734A (en)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643587A (en) * 1996-02-15 1997-07-01 Avon Products, Inc. Composition and method for under-eye skin lightening
WO2001019324A1 (en) * 1999-09-14 2001-03-22 Isao Horiuchi Cosmetics
WO2002064150A1 (en) * 2001-02-14 2002-08-22 Color Access, Inc. Whitening compositions containing ascomycete derived enzyme
WO2003072119A1 (en) * 2002-02-28 2003-09-04 Nihon Kefir Co., Ltd. External compositions for the skin
KR100466623B1 (en) * 2002-01-17 2005-01-15 주식회사 에스티씨나라 The culture medium for Kombucha fermentation, that has functions of skin regeneration and anti-aging, and composition containing thereof
JP2005348698A (en) * 2004-06-14 2005-12-22 Yonezawa Biru System Service:Kk Bacterium separated from kefir granule, bacterial culture obtained by culturing the bacterium or bacterium group containing the same and product obtained by using them
JP2006124290A (en) * 2004-10-27 2006-05-18 Yonezawa Biru System Service:Kk Microorganism cultured material obtained by culture medium containing mugwort extract as main ingredient and product using the same
JP2006219434A (en) * 2005-02-10 2006-08-24 Kyoei Kagaku Kogyo Kk Cosmetic
JP2006271219A (en) * 2005-03-28 2006-10-12 Yonezawa Biru System Service:Kk Cultured microorganism obtained from medium consisting mainly of green tea and black tea and product using the same
US7291340B2 (en) 2005-12-29 2007-11-06 Elc Management Llc Extracts from black yeast for whitening skin
JP2008255079A (en) * 2007-04-09 2008-10-23 Choi Jeong Hee Process for producing liquid phase component of basic skin care product using microorganisms
US20100203077A1 (en) * 2007-12-19 2010-08-12 Schnittger Steven F Compositions And Methods For Treating Skin With Extract From Trametes
US7862822B2 (en) 2007-09-25 2011-01-04 Elc Management Llc Extracts from black yeast for whitening skin
US20120121522A1 (en) * 2010-11-12 2012-05-17 Arch Personal Care Products, L.P. Metabolized conditioned growth medium and methods of use
JP5048246B2 (en) * 2003-08-26 2012-10-17 日本ケフィア株式会社 Internal composition for skin care
JP2019085331A (en) * 2017-11-01 2019-06-06 日本コルマー株式会社 Skin external preparation containing collagen fermentation liquid with saccharomyces yeast
CN113181086A (en) * 2021-04-06 2021-07-30 厦门医学院 Application of saussurea involucrata bacteria fermentation product in inhibiting tyrosinase activity and melanin generation

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643587A (en) * 1996-02-15 1997-07-01 Avon Products, Inc. Composition and method for under-eye skin lightening
EP0790054A1 (en) * 1996-02-15 1997-08-20 Avon Products, Inc. Composition and method for under-eye skin lightening
WO2001019324A1 (en) * 1999-09-14 2001-03-22 Isao Horiuchi Cosmetics
AU2002241873B2 (en) * 2001-02-14 2006-02-16 Color Access, Inc. Whitening compositions containing ascomycete derived enzyme
US6514506B1 (en) * 2001-02-14 2003-02-04 Color Access, Inc. Whitening compositions containing ascomycete derived enzyme
EP1289533A1 (en) * 2001-02-14 2003-03-12 Color Access, Inc. Whitening compositions containing ascomycete derived enzyme
EP1289533A4 (en) * 2001-02-14 2007-08-15 Color Access Inc Whitening compositions containing ascomycete derived enzyme
WO2002064150A1 (en) * 2001-02-14 2002-08-22 Color Access, Inc. Whitening compositions containing ascomycete derived enzyme
KR100466623B1 (en) * 2002-01-17 2005-01-15 주식회사 에스티씨나라 The culture medium for Kombucha fermentation, that has functions of skin regeneration and anti-aging, and composition containing thereof
WO2003072119A1 (en) * 2002-02-28 2003-09-04 Nihon Kefir Co., Ltd. External compositions for the skin
JP5048246B2 (en) * 2003-08-26 2012-10-17 日本ケフィア株式会社 Internal composition for skin care
JP2005348698A (en) * 2004-06-14 2005-12-22 Yonezawa Biru System Service:Kk Bacterium separated from kefir granule, bacterial culture obtained by culturing the bacterium or bacterium group containing the same and product obtained by using them
JP2006124290A (en) * 2004-10-27 2006-05-18 Yonezawa Biru System Service:Kk Microorganism cultured material obtained by culture medium containing mugwort extract as main ingredient and product using the same
JP2006219434A (en) * 2005-02-10 2006-08-24 Kyoei Kagaku Kogyo Kk Cosmetic
JP2006271219A (en) * 2005-03-28 2006-10-12 Yonezawa Biru System Service:Kk Cultured microorganism obtained from medium consisting mainly of green tea and black tea and product using the same
US7291340B2 (en) 2005-12-29 2007-11-06 Elc Management Llc Extracts from black yeast for whitening skin
JP2008255079A (en) * 2007-04-09 2008-10-23 Choi Jeong Hee Process for producing liquid phase component of basic skin care product using microorganisms
US7862822B2 (en) 2007-09-25 2011-01-04 Elc Management Llc Extracts from black yeast for whitening skin
US20100203077A1 (en) * 2007-12-19 2010-08-12 Schnittger Steven F Compositions And Methods For Treating Skin With Extract From Trametes
US8956624B2 (en) * 2007-12-19 2015-02-17 Elc Management, Llc Compositions and methods for treating skin with extract from Trametes
US20140037676A1 (en) * 2010-11-12 2014-02-06 Allergan, Inc. Process for preparing metabolized conditioned growth media
US20140037675A1 (en) * 2010-11-12 2014-02-06 Allergan, Inc. Process for preparing metabolized conditioned growth media
US20140037677A1 (en) * 2010-11-12 2014-02-06 Allergan, Inc. Process for preparing metabolized conditioned growth media
US20120121522A1 (en) * 2010-11-12 2012-05-17 Arch Personal Care Products, L.P. Metabolized conditioned growth medium and methods of use
US9408881B2 (en) * 2010-11-12 2016-08-09 Allergan, Inc. Topical composition
US10206961B2 (en) 2010-11-12 2019-02-19 Allergan, Inc. Process for preparing metabolized conditioned growth media
JP2019085331A (en) * 2017-11-01 2019-06-06 日本コルマー株式会社 Skin external preparation containing collagen fermentation liquid with saccharomyces yeast
CN113181086A (en) * 2021-04-06 2021-07-30 厦门医学院 Application of saussurea involucrata bacteria fermentation product in inhibiting tyrosinase activity and melanin generation
CN113181086B (en) * 2021-04-06 2023-11-17 厦门医学院 Application of saussurea involucrata fermentation product in inhibiting tyrosinase activity and melanin generation

Similar Documents

Publication Publication Date Title
JPH0710734A (en) Cosmetic
KR101826145B1 (en) Saccharomyces cerevisiae HEH EHWA and Autolysis Extract Manufactured Using Thereof
TWI668009B (en) Skin external agent for skin whitening comprising an extract of fermented wheat germ
JP2014530890A (en) Compositions containing extracts of continuous or simultaneous fermentation
Torres-Guererro et al. Melanin-deficient mutants of Cryptococcus neoformans
KR20170143053A (en) Cosmetic composition for improving anti-oxidation, anti-wrinkle and moisturizing comprising fermented product of used water from washing rice and preparation method of the same
KR100438009B1 (en) A cosmetic composition containing an extract of Grifola frondosa
KR20130114808A (en) Cosmetics composition including collagen natural fermented broth
KR20180111738A (en) Cosmetic composition for improving anti-oxidation, anti-wrinkle and moisturizing comprising fermented product of used water from washing rice and preparation method of the same
KR20200054590A (en) Composition for improving skin barrier comprising precipitation of fermented rice bran as active ingredient
KR20210046195A (en) Cosmetic composition for improving skin wrinkle comprising extract of clematic florida flower
KR20160045289A (en) Cosmetic Composition for Whitening of the Skin Comprising the Extract of Fermented Zea Mays Silk
CN114081862B (en) Preparation and application of Saccharomyces cerevisiae fermentation product from highland barley wine distiller's yeast in Pan-Himalaya region
KR20230061929A (en) Novel Bacillus endophyticus S2-11 strain
KR20040105601A (en) Cosmetic material
JPH0710735A (en) Cosmetic
FR3060568A1 (en) OLIGOPEPTIDE FRACTION OBTAINED FROM A BIOMASS OF BACTERIUM (S) BELONGING TO THE GENUS VITREOSCILLA SP. AS A COSMETIC ACTIVE
JP3466243B2 (en) Whitening cosmetics
KR20110105243A (en) Cosmetic composition for the skin whitening comprising phaseolus radiatus seed extracts by fermentation and enzyme treatment
EP0503763A1 (en) Cosmetic material
JP2904679B2 (en) Cosmetics
CN114533769B (en) Use of soybean mesotheca extract for resisting ultraviolet injury and reducing pigmentation
CN114699343B (en) Phellinus linteus fermentation product and preparation method thereof
KR102668617B1 (en) Leuconostoc mesenteroides strain and cosmetic composition containing the same
JPH08507506A (en) Collagenase activity inhibitors and cosmetic compositions containing such inhibitors